HEPATIQ™ LLC is an early stage company focused on diagnosing the severity of liver disease. Determining the stage of liver disease is essential to treatment planning and estimating the likelihood of adverse clinical outcomes including need for liver transplantation (which is expensive and of limited availability).
HEPATIQ™ LLC is privately held. It was founded on August 2, 2012 in Irvine, California by John Hoefs, MD and Dipu Ghosh, MSEE, MBA. For more information, please contact:
Dipu Ghosh, MSEE, MBA.
Co-Founder & Chief Executive Officer
John Hoefs, MD.
Co-Founder & Chief Operating Officer